Skip to main content
Top
Published in: Abdominal Radiology 6/2014

01-12-2014

Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients

Authors: Akshay D. Baheti, Sree Harsha Tirumani, Atul B. Shinagare, Michael H. Rosenthal, Jason L. Hornick, Nikhil H. Ramaiya, Brian M. Wolpin

Published in: Abdominal Radiology | Issue 6/2014

Login to get access

Abstract

Objective

To study the CT appearance and histopathology of mass-forming intrahepatic cholangiocarcinoma (IHCC) at presentation and correlate these features with metastatic disease and patient survival.

Materials and methods

In this IRB-approved, HIPAA compliant retrospective study, we reviewed pathology database of 459 patients with cholangiocarcinoma seen from 2004 through 2013 to identify 92 patients with IHCC (48 women, 44 men, mean age 61 years) who had CT scans of primary tumor available for review. All baseline and follow-up CT’s were reviewed by two radiologists in consensus to record imaging characteristics and metastatic patterns. Clinical and histopathology data were obtained from electronic medical records. Imaging patterns and histopathology were analyzed for associations with metastatic spread and survival.

Results

Three distinct CT patterns of IHCC at presentation were identified: solitary dominant mass (type I IHCC, n = 34), dominant mass with satellite nodules in same segment (type II IHCC, n = 19), and multiple scattered hepatic lesions (type III IHCC, n = 39). Distant metastases developed in 49/92 patients (53%); 39 (42%) of which were present at diagnosis. Lungs (22/92; 24%), peritoneum (17/92; 18%), and bones (13/92; 14%) were most common metastatic sites. Type I IHCC had smaller size, lowest incidence of metastases at presentation, and best overall survival, while type III IHCC had shortest survival (p < 0.017). Poorly differentiated IHCC had higher proportion of osseous metastases (p = 0.042) and worse survival (p = 0.027).

Conclusion

IHCC has three distinct CT patterns at presentation with different prognoses. Knowledge of these patterns can help radiologists to detect the extrahepatic disease and predict prognosis.
Literature
1.
go back to reference Khan SA, Davidson BR, Goldin R, et al. (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51(Suppl 6):VI1–VI9PubMedCentralPubMed Khan SA, Davidson BR, Goldin R, et al. (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51(Suppl 6):VI1–VI9PubMedCentralPubMed
2.
go back to reference Khan SA, Taylor-Robinson SD, Toledano MB, et al. (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37:806–813PubMedCrossRef Khan SA, Taylor-Robinson SD, Toledano MB, et al. (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37:806–813PubMedCrossRef
3.
go back to reference Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM (2006) Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extra-hepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 98:873–875PubMedCrossRef Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM (2006) Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extra-hepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 98:873–875PubMedCrossRef
4.
go back to reference Bragazzi MC, Cardinale V, Carpino G, et al. (2011) Cholangiocarcinoma: epidemiology and risk factors. Transl Gastrointest Cancer 1:21–32 Bragazzi MC, Cardinale V, Carpino G, et al. (2011) Cholangiocarcinoma: epidemiology and risk factors. Transl Gastrointest Cancer 1:21–32
5.
go back to reference Blechacz BR, Gores GJ (2008) Cholangiocarcinoma. Clin Liver Dis 12:131–150, ix Blechacz BR, Gores GJ (2008) Cholangiocarcinoma. Clin Liver Dis 12:131–150, ix
6.
go back to reference Nathan H, Aloia TA, Vauthey JN, et al. (2009) A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16:14–22PubMedCrossRef Nathan H, Aloia TA, Vauthey JN, et al. (2009) A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16:14–22PubMedCrossRef
8.
go back to reference Yamasaki S (2003) Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10:288–291PubMedCrossRef Yamasaki S (2003) Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10:288–291PubMedCrossRef
9.
10.
go back to reference Sb E (2009) AJCC cancer staging manual, 7th edn. New York: Springer Sb E (2009) AJCC cancer staging manual, 7th edn. New York: Springer
11.
go back to reference Greene FLPD, Fleming ID, et al. (2002) AJCC cancer staging manual, 6th edn. New York: SpringerCrossRef Greene FLPD, Fleming ID, et al. (2002) AJCC cancer staging manual, 6th edn. New York: SpringerCrossRef
12.
go back to reference de Jong MC, Nathan H, Sotiropoulos GC, et al. (2011) Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 29:3140–3145PubMedCrossRef de Jong MC, Nathan H, Sotiropoulos GC, et al. (2011) Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 29:3140–3145PubMedCrossRef
13.
go back to reference Farges O, Fuks D, Le Treut YP, et al. (2011) AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group. Cancer 117:2170–2177PubMedCrossRef Farges O, Fuks D, Le Treut YP, et al. (2011) AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group. Cancer 117:2170–2177PubMedCrossRef
14.
go back to reference Igami T, Ebata T, Yokoyama Y, et al. (2011) Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications. World J Surg 35:2501–2509PubMedCrossRef Igami T, Ebata T, Yokoyama Y, et al. (2011) Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications. World J Surg 35:2501–2509PubMedCrossRef
15.
go back to reference El Rassi ZE, Partensky C, Scoazec JY, et al. (1999) Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol 25:375–380PubMedCrossRef El Rassi ZE, Partensky C, Scoazec JY, et al. (1999) Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol 25:375–380PubMedCrossRef
16.
go back to reference Asayama Y, Yoshimitsu K, Irie H, et al. (2006) Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 238:150–155PubMedCrossRef Asayama Y, Yoshimitsu K, Irie H, et al. (2006) Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 238:150–155PubMedCrossRef
17.
go back to reference Loyer EM, Chin H, DuBrow RA, et al. (1999) Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT: a comparative study. Radiology 212:866–875PubMedCrossRef Loyer EM, Chin H, DuBrow RA, et al. (1999) Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT: a comparative study. Radiology 212:866–875PubMedCrossRef
18.
go back to reference Valls C, Guma A, Puig I, et al. (2000) Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25:490–496PubMedCrossRef Valls C, Guma A, Puig I, et al. (2000) Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25:490–496PubMedCrossRef
19.
go back to reference Fukukura Y, Hamanoue M, Fujiyoshi F, et al. (2000) Cholangiolocellular carcinoma of the liver: CT and MR findings. J Comput Assist Tomogr 24:809–812PubMedCrossRef Fukukura Y, Hamanoue M, Fujiyoshi F, et al. (2000) Cholangiolocellular carcinoma of the liver: CT and MR findings. J Comput Assist Tomogr 24:809–812PubMedCrossRef
20.
go back to reference Tsai S, Nathan H, Pawlik TM (2010) Primary liver cancer: intrahepatic cholangiocarcinoma emerges from the shadows. Updates Surg 62:5–9PubMedCrossRef Tsai S, Nathan H, Pawlik TM (2010) Primary liver cancer: intrahepatic cholangiocarcinoma emerges from the shadows. Updates Surg 62:5–9PubMedCrossRef
21.
go back to reference Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314PubMedCrossRef Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314PubMedCrossRef
22.
go back to reference Chung YE, Kim MJ, Park YN, et al. (2009) Varying appearances of cholangiocarcinoma: radiologic–pathologic correlation. Radiographics 29:683–700PubMedCrossRef Chung YE, Kim MJ, Park YN, et al. (2009) Varying appearances of cholangiocarcinoma: radiologic–pathologic correlation. Radiographics 29:683–700PubMedCrossRef
23.
go back to reference Sasaki A, Aramaki M, Kawano K, et al. (1998) Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg 85:1206–1209PubMedCrossRef Sasaki A, Aramaki M, Kawano K, et al. (1998) Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg 85:1206–1209PubMedCrossRef
24.
go back to reference Lim JH, Park CK (2004) Pathology of cholangiocarcinoma. Abdom Imaging 29:540–547PubMed Lim JH, Park CK (2004) Pathology of cholangiocarcinoma. Abdom Imaging 29:540–547PubMed
25.
go back to reference Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 181:819–827PubMedCrossRef Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 181:819–827PubMedCrossRef
26.
go back to reference Yamamoto J, Kosuge T, Takayama T, et al. (1992) Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than 5 years. Surgery 111:617–622PubMed Yamamoto J, Kosuge T, Takayama T, et al. (1992) Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than 5 years. Surgery 111:617–622PubMed
28.
go back to reference Kinsler V (2011) Satellite lesions in congenital melanocytic nevi-time for a change of name. Pediatr Dermatol 28:212–213PubMedCrossRef Kinsler V (2011) Satellite lesions in congenital melanocytic nevi-time for a change of name. Pediatr Dermatol 28:212–213PubMedCrossRef
29.
go back to reference Okabayashi T, Yamamoto J, Kosuge T, et al. (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92:2374–2383PubMedCrossRef Okabayashi T, Yamamoto J, Kosuge T, et al. (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92:2374–2383PubMedCrossRef
30.
go back to reference Kumar V, Robbins SL, Cotran RS (2010) Robbins and Cotran pathologic basis of disease, xiv. Philadelphia, PA: Saunders/Elsevier (1450 p) Kumar V, Robbins SL, Cotran RS (2010) Robbins and Cotran pathologic basis of disease, xiv. Philadelphia, PA: Saunders/Elsevier (1450 p)
31.
go back to reference Nakajima T, Kondo Y, Miyazaki M, Okui K (1988) A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 19:1228–1234PubMedCrossRef Nakajima T, Kondo Y, Miyazaki M, Okui K (1988) A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 19:1228–1234PubMedCrossRef
32.
go back to reference Compton CC, Fielding LP, Burgart LJ, et al. (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:979–994PubMed Compton CC, Fielding LP, Burgart LJ, et al. (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:979–994PubMed
33.
go back to reference DeOliveira ML, Cunningham SC, Cameron JL, et al. (2007) Cholangiocarcinoma: 31-year experience with 564 patients at a single institution. Ann Surg 245:755–762PubMedCentralPubMedCrossRef DeOliveira ML, Cunningham SC, Cameron JL, et al. (2007) Cholangiocarcinoma: 31-year experience with 564 patients at a single institution. Ann Surg 245:755–762PubMedCentralPubMedCrossRef
34.
go back to reference Bhuiya MR, Nimura Y, Kamiya J, et al. (1993) Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg 17:653–657PubMedCrossRef Bhuiya MR, Nimura Y, Kamiya J, et al. (1993) Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg 17:653–657PubMedCrossRef
35.
go back to reference Su CH, Tsay SH, Wu CC, et al. (1996) Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 223:384–394PubMedCentralPubMedCrossRef Su CH, Tsay SH, Wu CC, et al. (1996) Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 223:384–394PubMedCentralPubMedCrossRef
36.
go back to reference Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264:751–760PubMedCrossRef Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264:751–760PubMedCrossRef
Metadata
Title
Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients
Authors
Akshay D. Baheti
Sree Harsha Tirumani
Atul B. Shinagare
Michael H. Rosenthal
Jason L. Hornick
Nikhil H. Ramaiya
Brian M. Wolpin
Publication date
01-12-2014
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2014
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0167-0

Other articles of this Issue 6/2014

Abdominal Radiology 6/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.